EVEREST PHARMACY LTDActive

Company number 06964906Private limited companyIncorporated 2009

Key figures

£1,026,042+0.5%
Net assets 2024/25
+16.4%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, EVEREST PHARMACY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand11,754208,372360,706305,589382,449
Total assets3,116,1892,891,0983,662,1343,463,6503,629,100
Total liabilities2,183,5011,545,8652,412,6222,442,8122,603,058
Net assets / total equity932,6881,345,2331,249,5121,020,8381,026,042
Average number of employees2833343938

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: EVEREST PHARMACY LTD

Company

EVEREST PHARMACY LTD is a private limited company registered with Companies House under company number 06964906. It was incorporated on 16 Jul 2009. Its status is active. The registered office is in Manchester (M16). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files small company accounts (filleted). Net assets were £1,026,042, up 0.5% on the previous year. Cash at bank and in hand was £382,449. Total assets were £3,629,100 and total liabilities £2,603,058. The company had an average of 38 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 4 of 7 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 May 2027. The next confirmation statement is due by 6 Sep 2027.